<DOC>
	<DOCNO>NCT02085824</DOCNO>
	<brief_summary>The purpose study determine follow drug : enoxaparin , dabigatran rivaroxaban cause least blood loss total hip replacement ( THR ) .</brief_summary>
	<brief_title>Comparison Blood Loss Following Total Hip Arthroplasty With Use Three Thromboprophylactic Regimes : Dabigatran , Enoxaparin Rivaroxaban .</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Osteoarthritis , Hip</mesh_term>
	<mesh_term>Dabigatran</mesh_term>
	<mesh_term>Rivaroxaban</mesh_term>
	<criteria>primary , endstage hip osteoarthritis require total hip arthroplasty inflammatory arthropathy liver disorder neoplastic condition clot disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>